Literature DB >> 10827430

Evolutionarily conserved proteins as prominent immunogens during Leishmania infections.

J M Requena1, C Alonso, M Soto.   

Abstract

Many Leishmania antigens have been identified as members of conserved protein families, such as the acidic ribosomal proteins, the histones and the heat-shock proteins; despite this, they elicit specific immune responses. Furthermore, homologues of many of these antigens are immune targets in other infectious diseases and systemic autoimmune diseases. Here, Jose Mar a Requena, Carlos Alonso and Manuel Soto review this class of widely distributed antigens, which they call 'panantigens'. They also propose a model to explain the prominent immunogenicity of these antigens during Leishmania infection, on the basis of the fact that many panantigens are constituents of multicomponent complexes in the cell. The elucidation of the pathways by which Leishmania antigens are processed and presented to effector cells from the host immune system will shed light on the immunopathology of leishmaniasis and help in the development of protective immunotherapies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10827430     DOI: 10.1016/s0169-4758(00)01651-3

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  35 in total

1.  The sera from adult patients with suggestive signs of autoimmune diseases present antinuclear autoantibodies that cross-react with Leishmania infantum conserved proteins: crude Leishmania histone and Soluble Leishmania antigens [corrected].

Authors:  Sami Lakhal; Meriem Benabid; Ines Ben Sghaier; Jihen Bettaieb; Aïda Bouratbine; Yousr Galai
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

2.  The Leishmania infantum PUF proteins are targets of the humoral response during visceral leishmaniasis.

Authors:  Cristina Folgueira; Marta Martínez-Bonet; Jose M Requena
Journal:  BMC Res Notes       Date:  2010-01-21

3.  Evaluation of an enzyme-linked immunosorbent assay based on crude Leishmania histone proteins for serodiagnosis of human infantile visceral leishmaniasis.

Authors:  Sami Lakhal; Salima Mekki; Imène Ben-Abda; Mohamed Mousli; Fethi Amri; Karim Aoun; Aïda Bouratbine
Journal:  Clin Vaccine Immunol       Date:  2012-07-18

4.  Effect of A2 gene on infectivity of the nonpathogenic parasite Leishmania tarentolae.

Authors:  Amir Mizbani; Yasaman Taslimi; Farnaz Zahedifard; Tahereh Taheri; Sima Rafati
Journal:  Parasitol Res       Date:  2011-03-26       Impact factor: 2.289

5.  Dual role of the Leishmania major ribosomal protein S3a homologue in regulation of T- and B-cell activation.

Authors:  A Cordeiro-Da-Silva; M C Borges; E Guilvard; A Ouaissi
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

6.  An antigenic domain of the Leishmania amazonensis nucleoside triphosphate diphosphohydrolase (NTPDase 1) is associated with disease progression in susceptible infected mice.

Authors:  M L Detoni; M R Fessel; A C R G Maia; G N Porcino; L R Quellis; P Faria-Pinto; M J Marques; M A Juliano; L Juliano; V A Diniz; S Côrte-Real; S C Gonçalves-da-Costa; C S F Souza; E G Vasconcelos
Journal:  Parasitol Res       Date:  2013-05-17       Impact factor: 2.289

7.  The Leishmania infantum acidic ribosomal protein P0 administered as a DNA vaccine confers protective immunity to Leishmania major infection in BALB/c mice.

Authors:  Salvador Iborra; Manuel Soto; Javier Carrión; Ana Nieto; Edgar Fernández; Carlos Alonso; Jose M Requena
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

8.  Antigenicity of Leishmania braziliensis histone H1 during cutaneous leishmaniasis: localization of antigenic determinants.

Authors:  Emma Carmelo; Enrique Martínez; Ana Cristina González; José Enrique Piñero; Manuel E Patarroyo; Antonio Del Castillo; Basilio Valladares
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

9.  Specific serodiagnosis of canine visceral leishmaniasis using Leishmania species ribosomal protein extracts.

Authors:  Eduardo A F Coelho; Laura Ramírez; Mariana A F Costa; Vinicio T S Coelho; Vivian T Martins; Miguel A Chávez-Fumagalli; Dulcilene M Oliveira; Carlos A P Tavares; Pedro Bonay; Carlos Gómez Nieto; Daniel R Abánades; Carlos Alonso; Manuel Soto
Journal:  Clin Vaccine Immunol       Date:  2009-10-07

10.  Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis.

Authors:  J Moreno; J Nieto; S Masina; C Cañavate; I Cruz; C Chicharro; E Carrillo; S Napp; C Reymond; P M Kaye; D F Smith; N Fasel; J Alvar
Journal:  Vaccine       Date:  2007-06-04       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.